In financial year 2024, Gland pharma Limited's revenue from operation was valued at over 56 billion Indian rupees. This Indian company was acquired by Fosun Pharmaceuticals, a Chinese listed pharmaceutical company in 2016.
Revenue of Gland Pharma Limited from financial year 2018 to 2024
(in billion Indian rupees)
Profit from the additional features of your individual account
Currently, you are using a shared account. To use individual functions (e.g., mark statistics as favourites, set
statistic alerts) please log in with your personal account.
If you are an admin, please authenticate by logging in again.
Learn more about how Statista can support your business.
Gland Pharma. (August 9, 2024). Revenue of Gland Pharma Limited from financial year 2018 to 2024 (in billion Indian rupees) [Graph]. In Statista. Retrieved November 21, 2024, from https://www.statista.com/statistics/1186767/india-gland-pharma-revenue/
Gland Pharma. "Revenue of Gland Pharma Limited from financial year 2018 to 2024 (in billion Indian rupees)." Chart. August 9, 2024. Statista. Accessed November 21, 2024. https://www.statista.com/statistics/1186767/india-gland-pharma-revenue/
Gland Pharma. (2024). Revenue of Gland Pharma Limited from financial year 2018 to 2024 (in billion Indian rupees). Statista. Statista Inc.. Accessed: November 21, 2024. https://www.statista.com/statistics/1186767/india-gland-pharma-revenue/
Gland Pharma. "Revenue of Gland Pharma Limited from Financial Year 2018 to 2024 (in Billion Indian Rupees)." Statista, Statista Inc., 9 Aug 2024, https://www.statista.com/statistics/1186767/india-gland-pharma-revenue/
Gland Pharma, Revenue of Gland Pharma Limited from financial year 2018 to 2024 (in billion Indian rupees) Statista, https://www.statista.com/statistics/1186767/india-gland-pharma-revenue/ (last visited November 21, 2024)
Revenue of Gland Pharma Limited from financial year 2018 to 2024 (in billion Indian rupees) [Graph], Gland Pharma, August 9, 2024. [Online]. Available: https://www.statista.com/statistics/1186767/india-gland-pharma-revenue/